Accumulating evidence has shown that depletion of OTUB1 sensitizes multiple tumor cells to ferrotopsis, including glioma 141, colon cancer 142, breast cancer 143, and pancreatic cancer 144, thereby modulating OTUB1 might be a promising strategy for cancer therapy. This evidence concerns the gene OTUB1 and central nervous system cancer.